End-of-cancer therapy cardiovascular risk assessment and long-term follow-up.

Back

Open Access

End-of-cancer therapy cardiovascular risk assessment and long-term follow-up.

Session: 2022 ESC Guidelines on cardio-oncology

Topic: Cardio-Oncology

Speaker: Professor T. Suter (Bern, CH)

Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Thomas Suter

Bern University Hospital, Inselspital, Bern (Switzerland)

17 presentations

5 followers

3 more presentations in this session

Cardiovascular toxicity risk stratification before anticancer therapy.

Speaker: Doctor E. de Azambuja (Brussels, BE)

Access

Slides

Video

Prevention and monitoring of cardiovascular complications during cancer therapy.

Speaker: Professor J. Bergler-Klein (Vienna, AT)

Access

Slides

Video

Diagnosis and management of acute and subacute CVDs in patients with active cancer.

Speaker: Associate Professor D. Farmakis (Athens, GR)

Access

Slides

Video

Access the full session

2022 ESC Guidelines on cardio-oncology

Speakers: Professor T. Suter, Doctor E. de Azambuja, Professor J. Bergler-Klein, Associate Professor D. Farmakis

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

End-of-cancer therapy cardiovascular risk assessment and long-term follow-up.

About the speaker

Professor Thomas Suter

3 more presentations in this session

Cardiovascular toxicity risk stratification before anticancer therapy.

Prevention and monitoring of cardiovascular complications during cancer therapy.

Diagnosis and management of acute and subacute CVDs in patients with active cancer.

Access the full session

2022 ESC Guidelines on cardio-oncology

About the event

ESC Congress 2022

ESC 365 is supported by